drugset / Trial / NCT00178919

Nitric Oxide and the Autonomic Nervous System

NCT00178919

Completed 112 enrolled Vanderbilt University
Non-randomizedParallel-groupSingle-blind

Summary

The amount of blood flowing to the different parts of the body is regulated by the autonomic (automatic) nerves and by local factors produced by the blood vessels. Nitric oxide (NO) is one of the most important of these metabolic factors. If the production of NO is slowed or stopped the amount of blood to the different parts of the body is decreased. There is increasing knowledge that NO mechanisms are impaired in a number of medical conditions. NO function is reduced in patients with risk factors for atherosclerosis (hardening of the arteries) such as hypercholesterolemia (patients with high cholesterol), or diabetes mellitus, and is also impaired in smokers. This NO "deficiency" is believed to contribute to the greater cardiovascular risk that marks these patient populations. This study is designed to examine if endothelial nitric oxide is an important control mechanism of blood pressure under normal conditions, and if impairment of nitric oxide contributes to hypertension.

Timeline

Start
2002-08
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject L-NMMA Unknown 125 ug/kg Intravenous
Subject L-NMMA Unknown 250 ug/kg Intravenous
Subject L-NMMA Unknown 500 ug/kg Intravenous
Background Trimethaphan Small molecule 4 mg Intravenous
Background Trimethaphan Small molecule 6 mg Intravenous